Researchers at Adaptimmune and the University of Pennsylvania announce the approval of an IND and opening for enrolment of the first ever study using engineered T cells to treat HIV
October 7th, 2009 Oxford, UK and Philadelphia, PA: 7 October 2009. Researchers at Adaptimmune Limited and the University of Pennsylvania School of Medicine announce the approval of an Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) and opening for enrolment of the first ever study using patients’ cells carrying an [...]
Click below to download Press Release :- Adaptimmune Ltd Press Release – 09 Nov 2008
Adaptimmune was officially founded on the 1st July 2008 with the remit of advancing the use of engineered T cell receptors in adoptive T cell therapy.
